The incidence of human papillomavirus infection following treatment for cervical neoplasia: A systematic review

Gynecologic Oncology

Volumn 132, Issue 3, 2014, Pages 767-779

  Rositch, Anne F ^a,b   Soeters, Heidi M ^c   Offutt Powell, Tabatha N ^c   Wheeler, Bradford S ^c   Taylor, Sylvia M ^d   Smith, Jennifer S ^c,e  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c University of North Carolina at Chapel Hill   (United States)

^d GSK   (Belgium)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Cervical neoplasia; Cryotherapy; Human papillomavirus; Incidence; LEEP; Post treatment

Indexed keywords

ALPHA INTERFERON;

CRYOTHERAPY; FOLLOW UP; HUMAN; INCIDENCE; INFECTION RISK; INFORMATION RETRIEVAL; LASER SURGERY; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT INDICATION; UTERINE CERVIX CONIZATION; UTERINE CERVIX TUMOR;

CERVICAL NEOPLASIA; CRYOTHERAPY; HUMAN PAPILLOMAVIRUS; INCIDENCE; LEEP; POST-TREATMENT;

CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; INCIDENCE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 84896400001     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.12.040     Document Type: Review

References (52)

1. Centers for Disease C, Prevention Progress toward implementation of human papillomavirus vaccination - the Americas, 2006-2010 MMWR Morb Mortal Wkly Rep 60 2011 1382 1384
2. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet] GLOBOCAN 2008 v12 2010 International Agency for Research on Cancer Lyon, France
3. J.T. Cox Epidemiology of cervical intraepithelial neoplasia: the role of human papillomavirus Baillieres Clin Obstet Gynaecol 9 1995 1 37
4. T.C. Wright Jr., L.S. Massad, C.J. Dunton, M. Spitzer, E.J. Wilkinson, and D. Solomon et al. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ Am J Obstet Gynecol 197 2007 340 345
5. W.P. Soutter, P. Sasieni, and T. Panoskaltsis Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia Int J Cancer 118 2006 2048 2055
6. Y. Nagai, T. Maehama, T. Asato, and K. Kanazawa Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence? Gynecol Oncol 79 2000 294 299
7. M.A. Nobbenhuis, C.J. Meijer, A.J. van den Brule, L. Rozendaal, F.J. Voorhorst, and E.K. Risse et al. Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia Br J Cancer 84 2001 796 801
8. K.L. Chua, and A. Hjerpe Human papillomavirus analysis as a prognostic marker following conization of the cervix uteri Gynecol Oncol 66 1997 108 113
9. R. Tachezy, I. Mikyskova, V. Ludvikova, L. Rob, T. Kucera, and V. Slavik et al. Longitudinal study of patients after surgical treatment for cervical lesions: detection of HPV DNA and prevalence of HPV-specific antibodies Eur J Clin Microbiol Infect Dis 25 2006 492 500
10. L.J. Bollen, A.H.S.P. Tjong, J. van der Velden, B.W. Mol, F.W. ten Kate, and J. ter Schegget et al. Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology Gynecol Oncol 72 1999 199 201
11. F.X. Bosch, M.M. Manos, N. Munoz, M. Sherman, A.M. Jansen, and J. Peto et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group J Natl Cancer Inst 87 1995 796 802
12. J. Verguts, B. Bronselaer, G. Donders, M. Arbyn, J. Van Eldere, and M. Drijkoningen et al. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation BJOG 113 2006 1303 1307
13. K.J. Rothman, S. Greenland, and T.L. Lash Modern epidemiology III ed. 2008 Lippincott, Williams & Wilkins New York
14. M. Kocken, T.J. Helmerhorst, J. Berkhof, J.A. Louwers, M.A. Nobbenhuis, and A.G. Bais et al. Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study Lancet Oncol 12 2011 441 450
15. A.G. Bais, M.J. Eijkemans, M. Rebolj, P.J. Snijders, R.H. Verheijen, and M. van Ballegooijen et al. Post-treatment CIN: randomised clinical trial using hrHPV testing for prediction of residual/recurrent disease Int J Cancer 124 2009 889 895
16. P.E. Castle, A.R. Kreimer, S. Wacholder, C.M. Wheeler, L.A. Koutsky, and G. Rydzak et al. Influence of loop electrosurgical excision procedure on subsequent acquisition of new human papillomavirus infections J Infect Dis 199 2009 1612 1620
17. S. Taylor, C. Wang, T.C. Wright, L. Denny, W.Y. Tsai, and L. Kuhn Reduced acquisition and reactivation of human papillomavirus infections among older women treated with cryotherapy: results from a randomized trial in South Africa BMC Med 8 2010 40
18. J. Heymans, I.H. Benoy, W. Poppe, and C.E. Depuydt Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation Int J Cancer 129 2011 903 909
19. A.M. Dunham, J.C. McCartney, D.J. McCance, and R.W. Taylor Effect of perilesional injection of alpha-interferon on cervical intraepithelial neoplasia and associated human papillomavirus infection J R Soc Med 83 1990 490 492
20. M. Brodman, P. Dottino, F. Friedman Jr., D. Heller, I. Bleiweiss, and R. Sperling Human papillomavirus-associated lesions of the vagina and cervix. Treatment with a laser and topical 5-fluorouracil J Reprod Med 37 1992 453 456
21. K. Elfgren, M. Jacobs, J.M. Walboomers, C.J. Meijer, and J. Dillner Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia Obstet Gynecol 100 2002 965 971
22. M.A. van Ham, D. van Hamont, R.L. Bekkers, J. Bulten, W.J. Melchers, and L.F. Massuger High-risk HPV presence in cervical specimens after a large loop excision of the cervical transformation zone: significance of newly detected hr-HPV genotypes J Med Virol 79 2007 314 319
23. N. Nagai, K. Mukai, T. Oshita, Y. Shiroyama, and K. Ohama Human papillomavirus DNA status after loop excision for cervical intraepithelial neoplasia grade III - a prospective study Int J Mol Med 13 2004 589 593
24. L.O. Sarian, S.F. Derchain, R. Pitta Dda, S.S. Morais, and S.H. Rabelo-Santos Factors associated with HPV persistence after treatment for high-grade cervical intra-epithelial neoplasia with large loop excision of the transformation zone (LLETZ) J Clin Virol 31 2004 270 274
25. S.H. Song, J.K. Lee, M.J. Oh, J.Y. Hur, J.Y. Na, and Y.K. Park et al. Persistent HPV infection after conization in patients with negative margins Gynecol Oncol 101 2006 418 422
26. 2 conization for high-grade cervical intraepithelial neoplasia Gynecol Oncol 109 2008 59 64
27. A. Aerssens, P. Claeys, E. Beerens, A. Garcia, S. Weyers, and L. Van Renterghem et al. Prediction of recurrent disease by cytology and HPV testing after treatment of cervical intraepithelial neoplasia Cytopathology 20 2009 27 35
28. K. Nam, S. Chung, J. Kim, S. Jeon, and D. Bae Factors associated with HPV persistence after conization in patients with negative margins J Gynecol Oncol 20 2009 91 95
29. R.L. Bekkers, W.J. Melchers, J.M. Bakkers, A.G. Hanselaar, W.G. Quint, and H. Boonstra et al. The role of genotype-specific human papillomavirus detection in diagnosing residual cervical intraepithelial neoplasia Int J Cancer 102 2002 148 151
30. A. Baloglu, D. Uysal, I. Bezircioglu, M. Bicer, and A. Inci Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions Arch Gynecol Obstet 282 2010 69 73
31. 2 laser surgery in treating squamous intraepithelial lesions. An analysis of clinical and virologic results J Reprod Med 39 1994 441 444
32. A.L. Distefano, M.A. Picconi, L.V. Alonio, D. Dalbert, J. Mural, and O. Bartt et al. Persistence of human papillomavirus DNA in cervical lesions after treatment with diathermic large loop excision Infect Dis Obstet Gynecol 6 1998 214 219
33. L. Kjellberg, G. Wadell, F. Bergman, M. Isaksson, T. Angstrom, and J. Dillner Regular disappearance of the human papillomavirus genome after conization of cervical dysplasia by carbon dioxide laser Am J Obstet Gynecol 183 2000 1238 1242
34. J. Melnikow, C. McGahan, G.F. Sawaya, T. Ehlen, and A. Coldman Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study J Natl Cancer Inst Monogr 101 2009 721 728
35. A.R. Kreimer, M. Schiffman, R. Herrero, A. Hildesheim, P. Gonzalez, and R.D. Burk et al. Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment Int J Cancer 131 2012 211 218
36. W.D. Kang, M.J. Oh, S.M. Kim, J.H. Nam, C.S. Park, and H.S. Choi Significance of human papillomavirus genotyping with high-grade cervical intraepithelial neoplasia treated by a loop electrosurgical excision procedure Am J Obstet Gynecol 203 72 2010 e1 e6
37. J. Jones, A. Saleem, N. Rai, T.S. Shylasree, S. Ashman, and K. Gregory et al. Human Papillomavirus genotype testing combined with cytology as a 'test of cure' post treatment: the importance of a persistent viral infection J Clin Virol 52 2011 88 92
38. R. Ribaldone, R. Boldorini, A. Capuano, S. Arrigoni, A. Di Oto, and N. Surico Role of HPV testing in the follow-up of women treated for cervical dysplasia Arch Gynecol Obstet 282 2010 193 197
39. E.A. Joura, S.M. Garland, J. Paavonen, D.G. Ferris, G. Perez, and K.A. Ault et al. Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data BMJ 344 2012 e1401
40. K.A. Swedish, S.H. Factor, and S.E. Goldstone Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study Clin Infect Dis 54 2012 891 898
41. W.D. Kang, H.S. Choi, and S.M. Kim Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)? Gynecol Oncol 130 2013 264 268
42. A.F. Rositch, A.E. Burke, R.P. Viscidi, M.I. Silver, K. Chang, and P.E. Gravitt Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women Cancer Res 72 2012 6183 6190
43. P.E. Castle, M. Schiffman, R. Herrero, A. Hildesheim, A.C. Rodriguez, and M.C. Bratti et al. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica J Infect Dis 191 2005 1808 1816
44. E.L. Franco, L.L. Villa, J.P. Sobrinho, J.M. Prado, M.C. Rousseau, and M. Desy et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer J Infect Dis 180 1999 1415 1423
45. M. Kocken, M.H. Uijterwaal, A.L. de Vries, J. Berkhof, J.C. Ket, and T.J. Helmerhorst et al. High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: a systematic review and meta-analysis Gynecol Oncol 125 2012 500 507
46. R. Legood, M. Smith, J.B. Lew, R. Walker, S. Moss, and H. Kitchener et al. Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study BMJ 345 2012 e7086
47. L.S. Massad, M.H. Einstein, W.K. Huh, H.A. Katki, W.K. Kinney, and M. Schiffman et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors Obstet Gynecol 121 2013 829 846
48. S. Brismar, B. Johansson, M. Borjesson, M. Arbyn, and S. Andersson Follow-up after treatment of cervical intraepithelial neoplasia by human papillomavirus genotyping Am J Obstet Gynecol 201 17 2009 e1 e8
49. K. Elfgren, P. Bistoletti, L. Dillner, J.M. Walboomers, C.J. Meijer, and J. Dillner Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens Am J Obstet Gynecol 174 1996 937 942
50. S. Venturoli, S. Ambretti, M. Cricca, E. Leo, S. Costa, and M. Musiani et al. Correlation of high-risk human papillomavirus genotypes persistence and risk of residual or recurrent cervical disease after surgical treatment J Med Virol 80 2008 1434 1440
51. D. Wu, Y. Zheng, W. Chen, C. Guo, J. Yu, and G. Chen et al. Prediction of residual/recurrent disease by HPV genotype after loop excision procedure for high-grade cervical intraepithelial neoplasia with negative margins Aust N Z J Obstet Gynaecol 51 2011 114 118
52. R.L. Bekkers, J. Bulten, A. Wiersma-van Tilburg, M. Mravunac, C.P. Schijf, and L.F. Massuger et al. Coexisting high-grade glandular and squamous cervical lesions and human papillomavirus infections Br J Cancer 89 2003 886 890